This year, the annual congress of the International Society of Pharmacovigilance (ISoP) was held in Bogota, Colombia, between October 26th and 29th at the Grand Hyatt Hotel, where different experts gathered to discuss about pharmacovigilance -a topic that has become a science of global interest and rapid growth in recent decades- especially in regions such as Latin America.
What kind of surveillance should be implemented? What elements should be considered? What data is needed? These are just some of the questions developed in the discussions on the main topic of the congress: pharmacovigilance worldwide.
During these three days, the panelists focused on prescription failures and human, genetic factors; active pharmacovigilance including pharmacoepidemiology tools; safety of biological and biotechnological products; medication for women; herbal and traditional medications; risk communication; medical devices; support for patients’ access to medications; pharmacovigilance challenges in various geographical areas such as Latin America and specialties such as reproductive health; use of reports; possibility of improvement, among other vital issues.
All these discussions revolved around the construction of safe and effective health, which is imminently linked to a collective work between different areas of the sector that respond to the recommendation made by the experts: “Strengthen discussions between different actors: patients, educators, universities, PV associations, aligned with Mariano Madurga’s statement: think globally and act locally”.
Finally, it was emphasized the importance of teaching new generations the value of innovation in the health sector as an opportunity to anticipate a promising future for patients in terms of medical safety.